Categories AlphaGraphs, Earnings, Industrials

Infographic: Highlights of Ford Motor’s Q2 2022 earnings report

Auto giant Ford Motor Company (NYSE: F) on Wednesday reported higher sales and earnings for the second quarter of 2022. The company’s stock gained following the announcement.

Ford Motor Q2 2022 earnings infographic

Second-quarter revenues rose 50% annually to $40.2 billion. Automotive revenue grew 57% to $37.9 billion, which is well above the estimates. The company reported earnings of $0.68 per share, on an adjusted basis, up from last year’s profit of $0.13 per share. The market had predicted a slower growth.

On a reported basis, it was a net profit of $667 million or $0.16 per share, compared to $561 million or $0.14 per share in the second quarter of fiscal 2021.


Check this space to read management/analysts’ comments on Ford’s Q2 2022 earnings


Ford’s stock entered 2022 on a high note and reached a record high in early January, before slipping back to the pre-peak levels in the following weeks. The stock closed Wednesday’s trading higher, and gained further soon after the earnings announcement.

Prior Performance

  • Ford Motor Q4 2021 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

WMT Earnings: All you need to know about Walmart’s Q2 2023 earnings results

Walmart Inc. (NYSE: WMT) reported second quarter 2023 earnings results today. Total revenue increased 8.4% year-over-year to $152.9 billion. Revenues grew 9.1% in constant currency. Consolidated net income attributable to

Rivian (RIVN) reaffirms production goals. Will it be a smooth ride?

The evolution of the electric vehicle industry accelerated in recent years even as innovations in battery technology and affordability brought EVs into the mainstream. Encouraged by the success of market

Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term

Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a mixed sentiment surrounding the company’s growth prospects. Pfizer has benefited

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top